F. Hoffmann-La Roche Ltd
Companies and groups · Switzerland
In these lists: Biggest budgets, Medicines
- Declared lobbying cost
- €2,000,000 – €2,249,999 Financial year 01/2025-12/2025
- Commission meetings
- 5
- Full-time staff on EU lobbying
- 5.7
- European Parliament access passes
- 2
- Registered since
- 20 May 2009
Public records onlyWhat this means
Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself
Fields of interest
Budget, Business and industry, Climate action, Competition, Consumers, Digital economy and society, Economy, finance and the euro, Enlargement, Environment, External relations, Institutional affairs, International co-operation and development, Justice and fundamental rights, Public health, Research and innovation, Single market, Trade
Medicines and food topics they name
EU medicines law, Critical medicines, Orphan and paediatric medicine incentives, Health technology assessment
EU laws and policies they declare following1
- Roche aims to improve patient access to scientific innovation and to strengthen Europe's competitiveness. Our interactions with decision-makers relate to EU legislation and its implementation at nati…
Meetings with the Commission
Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them